A fluorinated poly(amino acid) nanovaccine with spatiotemporally encoded innate priming and antigen cross-presentation for tumor immunotherapy
Bioactive Materials · 2027-04 · 70 · 64-82
DOI: 10.1016/j.bioactmat.2026.10.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioactive Materials, 2027-04. Verfasst von Zijuan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Polymer Chemistry and Physics of Ministry of Education, School of Materials Science and Engineering, Peking University, Beijing, 10…. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Key Technologies Research and Development Program.
Abstract (Originalsprache)
The efficacy of cancer vaccines depends on spatiotemporally coordinated innate immune priming and antigen cross-presentation, but this hierarchy remains difficult to control with existing delivery platforms. Here, we report a fluorinated diethylenetriamine-modified poly(aspartic acid) nanovaccine platform, termed DET-F, and identify DET-F30 as the optimized formulation for antigen delivery and immune activation. Perfluorooctyl side chains promote early endosomal toll-like receptor 3 (TLR3) associated innate immune signaling and dendritic cell maturation, whereas the pH-responsive polymer backbone facilitates subsequent endosomal escape and cytosolic antigen release. This chemically encoded sequence enables delayed yet enhanced antigen cross-presentation in mature dendritic cells. DET-F30/antigen nanoparticles display efficient antigen loading and cellular uptake, activate TLR3-related innate immune pathways, and elicit robust antigen-specific CD8+ T cell immunity. In multiple tumor models, DET-F30-based vaccination suppresses tumor growth and metastasis, prolongs survival, and enhances post-surgical anti-PD-1 therapy. This work establishes fluorinated poly(amino acid)s as minimalist self-adjuvant nanovaccine vectors and demonstrates that precise polymer-architecture encoding can orchestrate sequential innate immune activation and antigen processing for improved cancer immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Polymer Chemistry and Physics of Ministry of Education, School of Materials Science and Engineering, Peking University, Beijing, 100871, China.
- Peking University School and Hospital of Stomatology, Peking University, Beijing, 100081, China.
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia.
Förderung
- National Natural Science Foundation of China
- Key Technologies Research and Development Program
Zitieren
APA
Wang, Z., Su, Y., Zhang, S., Yu, B., Wei, Y., Liu, H., Veselova, I. A., & Lv, S. (2027). A fluorinated poly(amino acid) nanovaccine with spatiotemporally encoded innate priming and antigen cross-presentation for tumor immunotherapy. Bioactive Materials, 70, 64-82. https://doi.org/10.1016/j.bioactmat.2026.10.034
Vancouver
Wang Z, Su Y, Zhang S, Yu B, Wei Y, Liu H, et al. A fluorinated poly(amino acid) nanovaccine with spatiotemporally encoded innate priming and antigen cross-presentation for tumor immunotherapy. Bioactive Materials. 2027;70:64-82. doi:10.1016/j.bioactmat.2026.10.034
BibTeX
@article{Wang2027,
author = {Wang, Zijuan and Su, Yuanzhen and Zhang, Shucheng and Yu, Bingzheng and Wei, Yan and Liu, Hao and Veselova, Irina A and Lv, Shixian},
title = {A fluorinated poly(amino acid) nanovaccine with spatiotemporally encoded innate priming and antigen cross-presentation for tumor immunotherapy},
journal = {Bioactive Materials},
year = {2027},
volume = {70},
pages = {64--82},
doi = {10.1016/j.bioactmat.2026.10.034}
}
EUVIMED